Published in Nat Med on January 09, 2011
Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome | NCT02153983
The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver Disease | NCT01619215
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74
Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91
Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 7.10
Inflammasomes in health and disease. Nature (2012) 6.75
Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 6.73
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 6.53
Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov (2012) 4.40
Immunological mechanisms of vaccination. Nat Immunol (2011) 3.35
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice. Nat Med (2013) 3.15
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol (2013) 3.08
Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J (2011) 3.04
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med (2013) 2.95
Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol (2011) 2.92
Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 2.92
The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature (2012) 2.87
A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol (2012) 2.59
Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med (2015) 2.59
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med (2015) 2.58
B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A (2013) 2.47
Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity (2013) 2.45
Age-dependent dysregulation of innate immunity. Nat Rev Immunol (2013) 2.44
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Sphingolipid metabolites in inflammatory disease. Nature (2014) 2.19
Immunological complications of obesity. Nat Immunol (2012) 2.09
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int (2014) 2.09
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev (2012) 2.01
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab (2014) 1.96
Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol (2012) 1.85
Immunological goings-on in visceral adipose tissue. Cell Metab (2013) 1.84
Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol (2012) 1.84
Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology (2011) 1.82
Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials (2012) 1.81
High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab (2012) 1.77
From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol (2013) 1.75
Cholesterol, inflammation and innate immunity. Nat Rev Immunol (2015) 1.72
NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol (2011) 1.69
Sensing damage by the NLRP3 inflammasome. Immunol Rev (2011) 1.69
Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc Natl Acad Sci U S A (2013) 1.64
Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes (2012) 1.62
Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol (2014) 1.62
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta (2013) 1.60
The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59
Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) (2012) 1.58
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol (2011) 1.56
New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54
Air pollution and type 2 diabetes: mechanistic insights. Diabetes (2012) 1.54
Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol (2017) 1.54
Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit Care Med (2014) 1.52
Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol (2013) 1.51
Macrophage polarization in inflammatory diseases. Int J Biol Sci (2014) 1.51
Low-grade inflammation, diet composition and health: current research evidence and its translation. Br J Nutr (2015) 1.50
TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One (2012) 1.48
Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology (2013) 1.48
Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) (2013) 1.47
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care (2012) 1.46
Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab (2013) 1.45
Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr (2012) 1.45
The immune system as a sensor of the metabolic state. Immunity (2013) 1.45
Macrophage polarization in metabolic disorders: functions and regulation. Curr Opin Lipidol (2011) 1.42
The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun (2012) 1.42
Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution. Proc Natl Acad Sci U S A (2016) 1.41
Innate and adaptive immune responses to cell death. Immunol Rev (2011) 1.40
Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation. PLoS One (2016) 1.40
Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. Nat Med (2017) 1.40
(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr (2011) 1.39
Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1. PLoS One (2016) 1.39
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes (2012) 1.38
Inflammasomes: far beyond inflammation. Nat Immunol (2012) 1.38
NOD1 activators link innate immunity to insulin resistance. Diabetes (2011) 1.38
Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat Immunol (2013) 1.36
What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes (2012) 1.35
Aldara activates TLR7-independent immune defence. Nat Commun (2013) 1.34
TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun (2013) 1.32
Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. Nat Med (2014) 1.31
Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol (2012) 1.31
Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes (2011) 1.30
Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol (2012) 1.30
Regulation of metabolism by the innate immune system. Nat Rev Endocrinol (2015) 1.29
Adipose tissue as an immunological organ. Obesity (Silver Spring) (2015) 1.27
The immune system's involvement in obesity-driven type 2 diabetes. Semin Immunol (2013) 1.25
Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. J Immunol (2014) 1.25
Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol Reprod (2014) 1.24
How metabolism generates signals during innate immunity and inflammation. J Biol Chem (2013) 1.22
Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One (2012) 1.21
Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein. J Biol Chem (2012) 1.20
TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res (2012) 1.19
Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function. Cell Rep (2014) 1.17
An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology. Front Immunol (2013) 1.17
Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes (2013) 1.16
Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes (2013) 1.14
Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J Biol Chem (2011) 1.14
The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep (2012) 1.14
NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med (Berl) (2014) 1.13
"Liking" and "wanting" of sweet and oily food stimuli as affected by high-fat diet-induced obesity, weight loss, leptin, and genetic predisposition. Am J Physiol Regul Integr Comp Physiol (2011) 1.13
Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol (2015) 1.13
Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.13
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol (2013) 1.12
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Inflammation and metabolic disorders. Nature (2006) 33.33
Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell (2002) 20.11
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science (2008) 16.54
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature (2004) 14.80
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity (2004) 13.55
Recognition of microorganisms and activation of the immune response. Nature (2007) 12.99
The inflammasomes: guardians of the body. Annu Rev Immunol (2009) 12.89
IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 12.07
Origin and physiological roles of inflammation. Nature (2008) 11.68
Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med (2007) 11.62
Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science (1995) 11.38
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 11.28
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 10.60
The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol (2008) 10.39
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol (2009) 9.24
Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med (2009) 8.15
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol (2009) 7.80
Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes (2007) 6.11
Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol (2009) 5.91
Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol (2008) 5.61
Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 5.10
Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest (2009) 5.09
Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab (2007) 4.94
Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol (2008) 4.75
A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol (2009) 4.19
Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 3.96
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol (2009) 3.85
Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet (2007) 3.59
Inflammasomes: guardians of cytosolic sanctity. Immunol Rev (2009) 3.58
Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest (1999) 3.36
Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem (2006) 3.20
Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab (2009) 3.10
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res (2008) 2.88
Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology (2006) 2.82
Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A (1989) 2.73
Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol (2010) 2.66
A proposed classification of the immunological diseases. PLoS Med (2006) 2.43
Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab (2008) 2.24
Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum (2009) 2.23
T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) (2010) 2.09
Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res (2005) 2.06
Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol (2009) 1.63
Obesity accelerates thymic aging. Blood (2009) 1.59
Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem (2008) 1.55
Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis (2009) 1.53
Cutting edge: Necrosis activates the NLRP3 inflammasome. J Immunol (2009) 1.50
Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes (2008) 1.44
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine (2008) 1.43
Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol (2008) 1.40
Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2009) 1.37
Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis (2008) 1.34
Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. Biochim Biophys Acta (2009) 1.22
Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med (2007) 3.92
A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82
Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr (2009) 3.59
Is it time to change the way we report and discuss weight loss? Obesity (Silver Spring) (2009) 3.57
Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am J Clin Nutr (2009) 3.56
Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr (2009) 3.39
Lateral hypothalamic area deep brain stimulation for refractory obesity: a pilot study with preliminary data on safety, body weight, and energy metabolism. J Neurosurg (2013) 3.31
Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr (2003) 3.11
Characterization of peripheral circadian clocks in adipose tissues. Diabetes (2006) 3.06
Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care (2006) 2.86
Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol (2010) 2.66
Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One (2009) 2.56
The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) (2010) 2.47
Validation study of energy expenditure and intake during calorie restriction using doubly labeled water and changes in body composition. Am J Clin Nutr (2007) 2.33
Effect of calorie restriction with or without exercise on body composition and fat distribution. J Clin Endocrinol Metab (2007) 2.33
Estimating the effects of energy imbalance on changes in body weight in children. Am J Clin Nutr (2006) 2.21
Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care (2012) 2.21
The peroxidase activity of mitochondrial superoxide dismutase. Free Radic Biol Med (2012) 2.14
A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr (2006) 2.12
Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab (2012) 2.11
Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab (2006) 2.09
Immunological complications of obesity. Nat Immunol (2012) 2.09
Effect of calorie restriction on resting metabolic rate and spontaneous physical activity. Obesity (Silver Spring) (2007) 2.06
Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab (2008) 2.02
Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care (2006) 1.96
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake. Cell Metab (2008) 1.94
Ghrelin promotes thymopoiesis during aging. J Clin Invest (2007) 1.83
Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology (2011) 1.82
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci (2010) 1.80
Self-report-based estimates of energy intake offer an inadequate basis for scientific conclusions. Am J Clin Nutr (2013) 1.79
Ten nights of moderate hypoxia improves insulin sensitivity in obese humans. Diabetes Care (2013) 1.75
Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol (2009) 1.74
Measurement of dietary restraint: validity tests of four questionnaires. Appetite (2006) 1.72
Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab (2009) 1.70
Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res (2005) 1.69
Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res (2003) 1.68
Circadian clocks are resounding in peripheral tissues. PLoS Comput Biol (2006) 1.66
Neuroimaging and obesity: mapping the brain responses to hunger and satiation in humans using positron emission tomography. Ann N Y Acad Sci (2002) 1.66
Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) (2008) 1.64
Low macrophage accumulation in skeletal muscle of obese type 2 diabetics and elderly subjects. Obesity (Silver Spring) (2012) 1.62
Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. Methods Mol Biol (2008) 1.62
Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J Biol Chem (2001) 1.61
Obesity accelerates thymic aging. Blood (2009) 1.59
Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis (2008) 1.58
Muscle-associated triglyceride measured by computed tomography and magnetic resonance spectroscopy. Obesity (Silver Spring) (2006) 1.49
Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice. Endocrinology (2003) 1.49
Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab (2013) 1.45
Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab (2008) 1.45
Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes (2008) 1.44
Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr (2005) 1.42
Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes. Antioxid Redox Signal (2010) 1.42
Metabolic slowing with massive weight loss despite preservation of fat-free mass. J Clin Endocrinol Metab (2012) 1.39
The role of mitochondria in health and disease. Curr Opin Pharmacol (2009) 1.37
Inactivation of PKCtheta leads to increased susceptibility to obesity and dietary insulin resistance in mice. Am J Physiol Endocrinol Metab (2006) 1.34
Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environ Health Perspect (2011) 1.34
Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health (2007) 1.33
Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals. J Clin Endocrinol Metab (2009) 1.32
Physical activity level and physical functionality in nonagenarians compared to individuals aged 60-74 years. J Gerontol A Biol Sci Med Sci (2007) 1.29
Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol (2009) 1.28
Adipose tissue as an immunological organ. Obesity (Silver Spring) (2015) 1.27
Skeletal muscle mitochondria and aging: a review. J Aging Res (2012) 1.27
Sex differences in the human brain's response to hunger and satiation. Am J Clin Nutr (2002) 1.25
Adipogenesis. Cold Spring Harb Perspect Biol (2012) 1.23
Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes (2009) 1.23
Assessing risk factors for obesity between childhood and adolescence: I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin. Pediatrics (2002) 1.23
Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells (2008) 1.23
Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process. Endocrine (2006) 1.23
Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring) (2006) 1.21
Development of adherence metrics for caloric restriction interventions. Clin Trials (2011) 1.21
Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring) (2012) 1.19
Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care (2009) 1.19
Ethnic-specific BMI and waist circumference thresholds. Obesity (Silver Spring) (2011) 1.18
The regulation of fatty acid synthase by STAT5A. Diabetes (2005) 1.16
Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2007) 1.16
HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell (2010) 1.16
Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J (2005) 1.15
Calorie restriction and bone health in young, overweight individuals. Arch Intern Med (2008) 1.14
The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep (2012) 1.14
STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes (2003) 1.14
Assessing risk factors for obesity between childhood and adolescence: II. Energy metabolism and physical activity. Pediatrics (2002) 1.14
Approaches for quantifying energy intake and %calorie restriction during calorie restriction interventions in humans: the multicenter CALERIE study. Am J Physiol Endocrinol Metab (2011) 1.13
Effect of caloric restriction in non-obese humans on physiological, psychological and behavioral outcomes. Physiol Behav (2008) 1.13
Induction of circadian gene expression in human subcutaneous adipose-derived stem cells. Obesity (Silver Spring) (2007) 1.13
Inactivation of the mitochondrial carrier SLC25A25 (ATP-Mg2+/Pi transporter) reduces physical endurance and metabolic efficiency in mice. J Biol Chem (2011) 1.11
High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Endocrinol Metab (2011) 1.10
Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation. Obes Res (2004) 1.10